跳至主要内容
临床试验/CTRI/2021/10/037338
CTRI/2021/10/037338招募中2 期

A Randomized Open Label Single Group Clinical Trial to Evaluate the Efficacy ofShwadanshtradi Rasayan in Rasakshay of Post Covid-19 patients.

Ashtang Ayurved Pharmacy Dhule0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • i)Patients of Post Covid-19 came under duration of > 21 days to 1 year after RTPCR report.
  • ii)Patients of Post covid â?? 19 showing classic
  • feature of Rasakshay[23].
  • iii)Patients between age group of 18-70 years will be included.
  • iv)The patients will be included after Shodhana.

排除标准

  • Patients with serious life threatening diseases will be
  • ii) Patients with age group below 18 and above 70 will be excluded.
  • iii) Pregnant women , children will be Excluded.

研究者

发起方
Ashtang Ayurved Pharmacy Dhule

相似试验